Anti-2019-nCoV RBD Antibody, ScFv(CLR28)
Product Type: ScFv Antibody
Formulation:
Liquid
Purity:
95%, determined by SDS-PAGE
Qty:
1 vial
Conc.:
0.9mg/ml
Total Amount:
100 μg
Target:
2019-nCoV Spike Protein (RBD)
Final buffer:
PBS, pH7.4
Endotoxin:
<1.0 EU per μg protein as determined by the LAL method
Method of
Purification:
The expression vectors of the antibody were transient transfected and expressed in
HEK293 cells with chemically defined culture media. The mAb was purified by Protein
A affinity chromatography and SEC, ultrafiltration and then subjected to 0.2 micro sterile
filtration to get the bulk of high purity.
Storage:
-20℃ to -80℃ for one year.
Avoid repeated freeze-thaw cycles
Note:
Cross-reactivity: SARS-CoV